Delivery Order SPE2DB22D2206-SPE2DB25FEX36

Award Date 12/30/24
Potential Completion Date 12/31/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery order SPE2DB24FNUL1, valued at $1,730.56, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the supply of 4,564,985,680 units of Sucralfate 1 GM/10 ML Suspension in 420 ML containers. This delivery order is placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 and runs...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,098.48 delivery order is for the supply of 90-count bottles of 1 gram Sucralfate tablets, a medication used to treat ulcers. The contract does not have a set-aside designation. As a key supplier to the U.S. federal government, AmerisourceBergen holds several high-value IDCs with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the provision of 4,564,658,926 Sucralfate 1 GM tablets in quantities of 90s. The contract has a total ceiling value of $39,774.64 and a period of performance through May 21, 2024. This order is placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of up to $999,999,999.00...
This firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,044.82, is for the delivery of 420 ml bottles of 1 gram/10 ml sucralfate suspension. The award has an ultimate completion date of March 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
The Defense Logistics Agency (DLA) awarded a $4,456.25 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 420mL of Sucralfate 1 gram/10mL suspension. This order was placed under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which runs through November 2026. The IDC enables AmerisourceBergen to efficiently deliver a comprehensive range of pharmaceutical products and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,095.67 contract is for the supply of 420 ml of Sucralfate 1 gram per 10 ml suspension, a medication used for the treatment of stomach and intestinal ulcers. The contract has a performance period through March 7, 2024 and is a firm fixed-price, delivery order under an Indefinite Delivery Contract (IDC) held...
This is a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical awarded to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of sucralfate 1 gram tablets, a pharmaceutical product used to treat digestive disorders. The delivery order has a ceiling value of $1,531.92 and is a firm fixed-price contract. The ultimate completion date for this order is September 26, 2024. Amerisourcebergen is a major supplier of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Sucralfate 1 GM Tablet 500s. The contract has a ceiling value of $1,063.68 and a completion date of November 30, 2023. The contract is a firm fixed-price, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 1 gram sucralfate tablets, a medication used to treat stomach and duodenal ulcers, with a ceiling value of $2,193.65 and a period of performance through January 6, 2025. The contract is not designated with a set-aside requirement, indicating open competition. It is associated with...
This is a Delivery Order (DO) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the supply of Sucralfate 1 GM/10 ML suspension in 420 ML bottles. The contract has a ceiling value of $4,962.23 and an ultimate completion date of September 9, 2024. The contract is for Firm Fixed Price (FFP) and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous Indefinite...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FEX36
    Delivery Order

This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,535.22 firm fixed-price order is for 4,566,812,259 units of Sucralfate 1 GM/10 ML Suspension, a medication used to treat stomach and duodenal ulcers. The IDC has a ceiling value of $999,999,999 and runs through November 2026, serving as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This order does not have a set-aside designation, indicating open competition. AmerisourceBergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 3/31/25, 9:30 AM